Idogen is a research company. The company's business focus is on developing vaccines for the treatment of diseases that adversely affect the immune system. The vaccines are intended to be used in the cases where autoimmune diseases have occurred and after organ rejection, particularly in the cases where antibodies have been formed against the ingestion of the regular medication of the patient. The company was founded in 2008 and is based in Lund.

Quotes for Idogen AB

Right Now

+/-
-0.045
%
-3,03%
Latest
1.44
High
1.5
Low
1.4
Volume
111 502
Turnover (SEK)
160 743
Value (MSEK)
69,8

Board

CEO

  • Anders Karlsson

Chairman Of The Board

  • Agneta Edberg

Board

  • Christina Herder
  • Karin Hoogendoorn
  • Leif G Salford

Videos

Upcoming reports

  • 2019-10-22 Delårsrapport 2019-Q3

  • 2020-02-11 Bokslutskommuniké 2019